Article
Six-Year Real-World Outcomes of Antivascular Endothelial Growth Factor Monotherapy and…
Journal of Ophthalmology · 2019 · Jingyuan Yang, author Mingzhen Yuan, author Song Xia, author Youxin Chen, author Ali Dirani, Guest Editor
Key facts
| Title | Six-Year Real-World Outcomes of Antivascular Endothelial Growth Factor Monotherapy and Combination Therapy for Various Subtypes of Polypoidal Choroidal Vasculopathy |
|---|---|
| First author | Jingyuan Yang, author Mingzhen Yuan, author Song Xia, author Youxin Chen, author Ali Dirani, Guest Editor |
| Journal | Journal of Ophthalmology |
| Published | Jul 24, 2019 |
| DOI | 10.1155/2019/1609717 |
| Devices mentioned | K101223, K113129, K121993, K152205, K172649, K173648, K181594, K182569, K192391, K201252, K223557, K240221 and 1 more |
| Product codes mentioned | HOO, OBO, MYC, MXK, HPT |
At a glance
- 10–99 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1